Drug:
Reaction: HAEMORRHAGE
20250101 - 20251231
No. 601 - 700
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 601 | 25067822 |
US |
65 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 602 | 25067931 |
US |
29 | 2 |
Haemorrhage, Maternal exposure during pregnancy, |
||||
SPIRONOLACTONE, HEPARIN SODIUM, HEPARIN SODIUM, WARFARIN, FENTANYL, MIFEPRISTONE, MISOPROSTOL, DOPAMINE HYDROCHLORIDE, DOPAMINE, |
||||
| 603 | 25068643 |
CN |
33 | 1 |
Haemorrhage, Myelosuppression, |
||||
CYTARABINE, |
||||
| 604 | 25068878 |
US |
62 | 1 |
Haemorrhage, |
||||
| 605 | 25069133 |
CA |
51 | 2 |
Nephrolithiasis, Eczema, Haemorrhage, Psoriasis, Weight increased, Off label use, |
||||
CLOPIDOGREL BISULFATE, AMLODIPINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, CANDESARTAN, CLONAZEPAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUTICASONE PROPIONATE, GABAPENTIN, IRON, PANTOPRAZOLE, SEMAGLUTIDE, |
||||
| 606 | 25069328 |
TW |
21 | 1 |
Contusion, Haemorrhage, Fall, |
||||
| 607 | 25069782 |
US |
2 | |
Renal failure, Coronary arterial stent insertion, Colectomy, Renal cancer, Haemorrhage, Lung disorder, COVID-19, Laboratory test abnormal, Product preparation error, |
||||
ALIROCUMAB, ALIROCUMAB, |
||||
| 608 | 25070442 |
US |
22 | 1 |
Haemorrhage, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, |
||||
| 609 | 25071019 |
US |
70 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE AND LIXISENATIDE, |
||||
| 610 | 25071095 |
US |
46 | 2 |
Pain, Discomfort, Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 611 | 25071096 |
US |
39 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 612 | 25071097 |
US |
59 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 613 | 25071332 |
DE |
85 | 2 |
Haemorrhage, Tooth extraction, Osteoarthritis, |
||||
RIVAROXABAN, RIVAROXABAN, |
||||
| 614 | 25071430 |
US |
||
Haemorrhage, Treatment noncompliance, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TIRZEPATIDE, |
||||
| 615 | 25071464 |
US |
23 | 1 |
Haemorrhage, Pain, Muscle spasms, Haematochezia, Flatulence, Abdominal pain, Proctalgia, Fatigue, Asthenia, Nausea, Decreased appetite, Diarrhoea, Mucous stools, Constipation, Frequent bowel movements, Defaecation urgency, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 616 | 25071475 |
US |
75 | 1 |
Haemorrhage, Aneurysm, Product use issue, Rash pruritic, |
||||
IXAZOMIB, IXAZOMIB, SPIRONOLACTONE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, FEXOFENADINE HYDROCHLORIDE, MAGNESIUM, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MONTELUKAST SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, APIXABAN, CLOPIDOGREL, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, MAGNESIUM HYDROXIDE, ALLOPURINOL, POLYETHYLENE GLYCOL 3350, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ONDANSETRON HYDROCHLORIDE, ALBUTEROL SULFATE, |
||||
| 617 | 25061342 |
CN |
16 | 1 |
Haemorrhage, Fall, Haemarthrosis, Haemarthrosis, Haemarthrosis, Pain, |
||||
| 618 | 25061464 |
PR |
78 | 1 |
Haemorrhage, Diverticulitis, |
||||
APIXABAN, |
||||
| 619 | 25061790 |
US |
64 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 620 | 25061798 |
US |
29 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 621 | 25061802 |
US |
64 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 622 | 25061960 |
US |
34 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 623 | 25061971 |
US |
88 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 624 | 25062075 |
US |
77 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 625 | 25062076 |
US |
63 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 626 | 25062214 |
US |
18 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 627 | 25062293 |
US |
58 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 628 | 25062294 |
US |
71 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 629 | 25062299 |
US |
73 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 630 | 25062738 |
US |
8 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 631 | 25062748 |
US |
67 | 1 |
Pain, Discomfort, Haemorrhage, |
||||
INSULIN GLARGINE, INSULIN ASPART, |
||||
| 632 | 25062756 |
US |
78 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 633 | 25062822 |
US |
2 | |
Haemorrhage, Haematochezia, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 634 | 25062953 |
GB |
22 | 2 |
Haematochezia, Fatigue, Balance disorder, Heavy menstrual bleeding, Groin pain, Flatulence, Delusion, Urinary tract infection, Candida infection, Constipation, Anal haemorrhage, Haemorrhage, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 635 | 25063056 |
GB |
22 | 2 |
Fatigue, Balance disorder, Flatulence, Groin pain, Delusion, Candida infection, Constipation, Haemorrhage, Haematochezia, Anal haemorrhage, Heavy menstrual bleeding, Urinary tract infection, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 636 | 25063305 |
US |
62 | 1 |
Haemorrhage, Discomfort, Pain, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 637 | 25063634 |
CA |
74 | 2 |
Ascites, Atrial fibrillation, Feeding disorder, Haemorrhage, Hepatic steatosis, Hypoalbuminaemia, Hypocalcaemia, Inflammation, Parenteral nutrition, Pancreatitis necrotising, Pleural effusion, SARS-CoV-2 test positive, Pancreatitis acute, Hyponatraemia, Abdominal pain, Vomiting, Generalised oedema, Diarrhoea, |
||||
RAMIPRIL, |
||||
| 638 | 25063875 |
US |
||
Atrial fibrillation, Gastrointestinal disorder, Gastrooesophageal reflux disease, Prostatitis, Haemorrhage, |
||||
RELUGOLIX, RELUGOLIX, APIXABAN, |
||||
| 639 | 25063952 |
US |
83 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 640 | 25064134 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 641 | 25064175 |
US |
19 | 1 |
Haemorrhage, Lip haemorrhage, Lip injury, |
||||
EMICIZUMAB, |
||||
| 642 | 25064310 |
US |
||
Haematochezia, Haemorrhage, Epistaxis, Therapy cessation, Intentional product use issue, |
||||
TICAGRELOR, |
||||
| 643 | 25064806 |
US |
75 | 2 |
Retinal disorder, Haemorrhage, Accidental underdose, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 644 | 25065120 |
US |
1 | |
Device issue, Needle issue, Haemorrhage, Product dose omission issue, Accidental exposure to product, |
||||
GUSELKUMAB, |
||||
| 645 | 25065305 |
US |
41 | 2 |
Haemorrhage, Retinal detachment, Blindness, Neuropathic arthropathy, Visual impairment, Vision blurred, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 646 | 25065452 |
US |
8 | 2 |
Haemorrhage, |
||||
SECUKINUMAB, |
||||
| 647 | 25065689 |
US |
53 | 1 |
Large intestinal ulcer, Visual impairment, Haemorrhage, |
||||
RISANKIZUMAB-RZAA, |
||||
| 648 | 25065693 |
US |
||
Pruritus, Haemorrhage, Anxiety, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 649 | 25065757 |
US |
||
Haemorrhage, Skin discolouration, Hypertension, |
||||
APIXABAN, |
||||
| 650 | 25067785 |
74 | 2 | |
Neutropenia, Fatigue, Haemorrhage, |
||||
LENALIDOMIDE, |
||||
| 651 | 25056411 |
US |
91 | 1 |
Haemorrhage, Blood glucose decreased, |
||||
INSULIN LISPRO, |
||||
| 652 | 25056536 |
US |
85 | 1 |
COVID-19, Haemorrhage, |
||||
| 653 | 25056648 |
US |
40 | 1 |
Haemorrhage, |
||||
| 654 | 25056671 |
US |
15 | 1 |
Haemorrhage, Peripheral swelling, Limb injury, |
||||
EMICIZUMAB, |
||||
| 655 | 25056680 |
US |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 656 | 25056685 |
US |
82 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 657 | 25056755 |
JP |
69 | 1 |
Cerebral infarction, Haemorrhage, Therapeutic product effect incomplete, |
||||
DABIGATRAN ETEXILATE MESYLATE, DABIGATRAN ETEXILATE MESYLATE, |
||||
| 658 | 25056800 |
US |
31 | 2 |
Haemorrhage, |
||||
INSULIN HUMAN, |
||||
| 659 | 25056801 |
US |
92 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 660 | 25056804 |
US |
63 | 2 |
Discomfort, Skin burning sensation, Erythema, Haemorrhage, Pain, Rash, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 661 | 25056824 |
US |
1 | |
Pain, Haemorrhage, |
||||
RISANKIZUMAB-RZAA, |
||||
| 662 | 25056867 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 663 | 25057278 |
US |
4 | 1 |
Weight increased, Haemorrhage, Fall, Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 664 | 25057315 |
US |
4 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 665 | 25057319 |
US |
87 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 666 | 25057401 |
US |
67 | 1 |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 667 | 25057402 |
US |
60 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 668 | 25057411 |
US |
63 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 669 | 25057850 |
US |
75 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 670 | 25057851 |
US |
76 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 671 | 25057858 |
US |
7 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 672 | 25057859 |
US |
13 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 673 | 25058022 |
US |
80 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 674 | 25058034 |
US |
85 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 675 | 25058897 |
US |
||
Gastrointestinal haemorrhage, Haemorrhage, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 676 | 25058967 |
US |
77 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 677 | 25058983 |
US |
50 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 678 | 25059229 |
US |
55 | 2 |
Gastrointestinal perforation, Haematemesis, Haemorrhage, Pruritus, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 679 | 25059605 |
FR |
84 | 2 |
Spontaneous haematoma, Blood loss anaemia, Haemorrhage, Product prescribing error, Nerve compression, Motor dysfunction, |
||||
SERTRALINE HYDROCHLORIDE, ENOXAPARIN SODIUM, |
||||
| 680 | 25059659 |
48 | 1 | |
Haemorrhage, |
||||
GLECAPREVIR AND PIBRENTASVIR, |
||||
| 681 | 25059791 |
DE |
5 | 1 |
Multiple organ dysfunction syndrome, Drug ineffective, Cardiovascular insufficiency, Hepatic failure, Renal failure, Haemorrhage, Aspergillus infection, Abdominal infection, Bronchopulmonary aspergillosis, Haemothorax, Off label use, Product use issue, |
||||
VORICONAZOLE, VORICONAZOLE, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, FLUCONAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, BASILIXIMAB, BASILIXIMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 682 | 25059801 |
DE |
1 | |
Haemorrhage, |
||||
EMICIZUMAB, VALOCTOCOGENE ROXAPARVOVEC-RVOX, |
||||
| 683 | 25059928 |
US |
28 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 684 | 25059929 |
US |
30 | 1 |
Haemorrhage, |
||||
EMICIZUMAB, |
||||
| 685 | 25059956 |
DE |
||
Haemorrhage, Thrombosis, General physical health deterioration, Hepatic function abnormal, Hepatic failure, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 686 | 25060278 |
US |
34 | 2 |
Haemorrhage, Injury, |
||||
| 687 | 25060284 |
US |
2 | |
Haemorrhage, |
||||
INSULIN GLARGINE, |
||||
| 688 | 25060648 |
US |
55 | 1 |
Haemorrhage, Rash, Erythema, Swelling, |
||||
AXITINIB, PEMBROLIZUMAB, |
||||
| 689 | 25060804 |
US |
2 | |
Haemorrhage, |
||||
RIVAROXABAN, |
||||
| 690 | 25060872 |
US |
6 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 691 | 25061026 |
US |
76 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 692 | 25061028 |
US |
47 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 693 | 25061031 |
US |
66 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 694 | 25061038 |
NL |
||
Haemorrhage, |
||||
MACITENTAN, |
||||
| 695 | 25061039 |
US |
80 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 696 | 25061050 |
US |
65 | 2 |
Haemorrhage, |
||||
INSULIN LISPRO, INSULIN DEGLUDEC, |
||||
| 697 | 25061068 |
US |
4 | 1 |
Haemorrhage, |
||||
INSULIN LISPRO, |
||||
| 698 | 25061160 |
CA |
3 | 1 |
Off label use, Epistaxis, Abdominal discomfort, Fatigue, Mood altered, Arthralgia, Drug ineffective, Haemorrhage, Irritability, Diarrhoea, Asthenia, Wrist fracture, Platelet count increased, |
||||
ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, ELTROMBOPAG OLAMINE, RITUXIMAB, |
||||
| 699 | 25061174 |
US |
1 | |
Calculus bladder, Haemorrhage, Urinary tract infection, Catheter site haemorrhage, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 700 | 25061188 |
GB |
80 | 2 |
Lower gastrointestinal haemorrhage, Melaena, Anaemia, Haemorrhage, Ulcer, Condition aggravated, |
||||
ENCORAFENIB, ENCORAFENIB, BINIMETINIB, BINIMETINIB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28